Skip to content

Clinical study of Qinggan Huashi Jiejiu Decoction combined with Tongluo Yanggan application in the treatment of alcoholic liver disease

Efficacy evaluation and mechanism study of Yiqi Huashi and Jiedu Tongluo methods in chronic liver disease

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2022000106
Enrollment
Unknown
Registered
2022-06-25
Start date
2022-11-11
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

alcoholic liver disease

Interventions

Treatment group:Qinggan Huashi Jiejiu Decoction combined with Tongluo Yanggan application

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for alcoholic liver disease and have liver function ALT, AST or ?-GT greater than 1.5 times the normal value at the time of enrollment; 2. Meet the the syndrome differentiation criteria of Ganyu Pixu and Shire Neijie; 3. The age is between 18-65 years old, and the gender is not limited; 4. Willing to participate in this research and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with other liver diseases such as hepatitis B and C; 2. Patients with autoimmune liver disease, drug-induced liver disease, toxic hepatitis, liver cancer, non-alcoholic fatty liver disease, occult hepatitis, and unexplained liver disease; 3. Pregnant or lactating women, those with allergic constitution; 4. Patients with mental disorders who cannot cooperate with this study; 5. Patients with severe heart, brain, lung, kidney, hematopoietic, immune and other system diseases; 6. Other conditions deemed inappropriate by the researcher.(including people with alcohol dependence)

Design outcomes

Primary

MeasureTime frame
lipid profile;liver function;CAP;LSM;liver ultrasound;

Countries

China

Contacts

Public Contactlvwenliang

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

lvwenliang@sohu.com18601237779

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026